MIM
ASTH icon

MetLife Investment Management’s Astrana Health ASTH Stock Holding History

MetLife Investment Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
26,603
+3,291
+14% +$118K 0.01% 1410
2026
Q1 		$572K Sell
23,312
-347
-1% -$8.22K ﹤0.01% 1687
2025
Q4 		$587K Sell
23,659
-2,215
-9% -$58.8K ﹤0.01% 1720
2025
Q3 		$734K Hold
25,874
– – ﹤0.01% 1625
2025
Q2 		$644K Hold
25,874
– – ﹤0.01% 1560
2025
Q1 		$802K Sell
25,874
-410
-2% -$13.7K ﹤0.01% 1469
2024
Q4 		$829K Buy
26,284
+1,173
+5% +$55.7K ﹤0.01% 1514
2024
Q3 		$1.45M Sell
25,111
-453
-2% -$22.3K 0.01% 1182
2024
Q2 		$1.04M Buy
25,564
+2,958
+13% +$117K 0.01% 1328
2024
Q1 		$949K Hold
22,606
– – 0.01% 1326
2023
Q4 		$866K Hold
22,606
– – 0.01% 1380
2023
Q3 		$697K Hold
22,606
– – 0.01% 1428
2023
Q2 		$714K Buy
22,606
+2,395
+12% +$82.1K 0.01% 1466
2023
Q1 		$737K Hold
20,211
– – 0.01% 1404
2022
Q4 		$598K Hold
20,211
– – ﹤0.01% 1523
2022
Q3 		$788K Hold
20,211
– – 0.01% 1316
2022
Q2 		$780K Hold
20,211
– – 0.01% 1352
2022
Q1 		$980K Buy
20,211
+7,056
+54% +$364K 0.01% 1340
2021
Q4 		$967K Hold
13,155
– – 0.01% 1142
2021
Q3 		$1.2M Hold
13,155
– – 0.01% 1043
2021
Q2 		$826K Buy
13,155
+3,742
+40% +$138K 0.01% 1281
2021
Q1 		$255K Hold
9,413
– – ﹤0.01% 1916
2020
Q4 		$172K Hold
9,413
– – ﹤0.01% 2058
2020
Q3 		$169K Buy
+9,413
New +$162K ﹤0.01% 1955
2019
Q4 		– Sell
-12,990
Closed -$229K – 2331
2019
Q3 		$229K Buy
+12,990
New +$222K ﹤0.01% 1872

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MetLife Investment Management's ASTH Position: Q2 2026 in Review

MetLife Investment Management increased its Astrana Health (ASTH) stake by 14% in Q2 2026, buying an estimated $118K and bringing the position to 26,603 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #1410.

MetLife Investment Management first reported a position in ASTH in Q3 2019 and has held it in 25 quarters since. The position peaked at $1.45M in Q3 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • MetLife Investment Management held 26,603 shares of Astrana Health worth $1.23M as of Q2 2026.
  • MetLife Investment Management bought 3,291 Astrana Health shares in Q2 2026, an estimated $118K.
  • Astrana Health made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1410 holding.
  • MetLife Investment Management first reported a position in Astrana Health in Q3 2019 and has held it in 25 quarters since.
  • MetLife Investment Management's Astrana Health position peaked at $1.45M in Q3 2024.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.